Sarah Lapointe
Impact in
- Genetics top 2%
- Glioma Diagnosis and Treatment
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Genetics 11
- Glioma Diagnosis and Treatment 11
-
- Brain Metastases and Treatment 5
- Renal cell carcinoma treatment 2
- Co-authors
- Arie Perry (3 shared papers)Nicholas Butowski (3 shared papers)Catherine Maurice (1 shared paper)Priti Gros (1 shared paper)Gregory S. Day (1 shared paper)David F. Tang‐Wai (1 shared paper)Richard Wennberg (1 shared paper)Claude Steriade (1 shared paper)
- Journals
- Neuro-Oncology (4 papers)Neurology (3 papers)Frontiers in Oncology (1 paper)Investigational New Drugs (1 paper)The Lancet (1 paper)
- Partner nations
- CanadaUnited States
In The Last Decade
Sarah Lapointe
14 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Genetics 438
- Cancer Research 312
- Neurology 92
- Molecular Biology 485
- Pulmonary and Respiratory Medicine 215
Countries citing papers authored by Sarah Lapointe
This map shows the geographic impact of Sarah Lapointe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Lapointe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Lapointe more than expected).
Fields of papers citing papers by Sarah Lapointe
This network shows the impact of papers produced by Sarah Lapointe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Lapointe. The network helps show where Sarah Lapointe may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarah Lapointe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Primary brain tumours in adults Hit paper breakdown → | 2018 | 983 |
| 2 | 2020 | 33 | |
| 3 | 2019 | 31 | |
| 4 | 2015 | 12 | |
| 5 | 2022 | 10 | |
| 6 | 2016 | 4 | |
| 7 | 2025 | 3 | |
| 8 | 2018 | 3 | |
| 9 | 2016 | 2 | |
| 10 | 2025 | 1 | |
| 11 | 2015 | 1 | |
| 12 | 2019 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 1 | |
| 15 | 2023 | 0 | |
| 16 | 2025 | 0 | |
| 17 | 2015 | 0 | |
| 18 | 2020 | 0 |
About Sarah Lapointe
Sarah Lapointe is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Neurology, Epidemiology and Surgery, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (11 papers), Brain Metastases and Treatment (5 papers), Meningioma and schwannoma management (5 papers), Diverticular Disease and Complications (2 papers), Renal cell carcinoma treatment (2 papers), Infectious Diseases and Tuberculosis (2 papers), Autoimmune Neurological Disorders and Treatments (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Genetics (438 citations), Cancer Research (312 citations), Neurology (92 citations), Molecular Biology (485 citations) and Pulmonary and Respiratory Medicine (215 citations). Sarah Lapointe has collaborated with scholars based in Canada and United States. Frequent co-authors include Arie Perry, Nicholas Butowski, Catherine Maurice, Priti Gros, Gregory S. Day, David F. Tang‐Wai, Richard Wennberg, Claude Steriade, Julien Hébert and Fatima Amtashar. Their work appears in journals such as Neuro-Oncology, Neurology, Frontiers in Oncology, Investigational New Drugs and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.